Basic information
Biomarker: MSH6
Histology type: endometrial carcinoma
Cohort characteristics
Country: Japan
Region: Tokorozawa
Study type: retrospective study
Followed up time :
Subgroup 1 name : retained
Subgroup 1 number: 164
Subgroup 2 name: loss
Subgroup 2 number: 27
Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
---|---|---|---|---|---|---|---|---|
191 | EC | 191 |
Sample information
Conclusion: MMR-related proteins expression was identified as an independent prognostic factor for OS, suggesting that MMR was a key biomarker for further investigations of endometrial cancers.
Sample type : tissue
Sample method: immunohistochemistry
Expression pattern : loss
Expression elevation: For all of the four markers detection, a nuclear immunoreaction was taken into account for evaluation. The lesions were considered as positive for each marker if tumor cells in the interest area showed immunoreactive intensity stronger than or equal to positive controls. The lesions were considered as negative for each marker if tumor cells showed complete loss of immunoreaction. Cases that at least one of four proteins was judged as negative were assigned to MMR-deficient cases and the remainder cases were assigned to MMR-retained cases.
Disease information
Related information
Funtion Uniprot: Component of the post-replicative DNA mismatch repair system (MMR). Heterodimerizes with MSH2 to form MutS alpha, which binds to DNA mismatches thereby initiating DNA repair. When bound, MutS alpha bends the DNA helix and shields approximately 20 base pairs, and recognizes single base mismatches and dinucleotide insertion-deletion loops (IDL) in the DNA. After mismatch binding, forms a ternary complex with the MutL alpha heterodimer, which is thought to be responsible for directing the downstream MMR events, including strand discrimination, excision, and resynthesis. ATP binding and hydrolysis play a pivotal role in mismatch repair functions. The ATPase activity associated with MutS alpha regulates binding similar to a molecular switch: mismatched DNA provokes ADP-->ATP exchange, resulting in a discernible conformational transition that converts MutS alpha into a sliding clamp capable of hydrolysis-independent diffusion along the DNA backbone. This transition is crucial for mismatch repair. MutS alpha may also play a role in DNA homologous recombination repair. Recruited on chromatin in G1 and early S phase via its PWWP domain that specifically binds trimethylated 'Lys-36' of histone H3 (H3K36me3): early recruitment to chromatin to be replicated allowing a quick identification of mismatch repair to initiate the DNA mismatch repair reaction.
UniProt ID: P52701
UniProt Link: https://www.uniprot.org/uniprotkb/P52701/entry
Biological function from UniProt: #DNA damage #DNA repair #Host-virus interaction
Molecular function from UniProt:
Subcellular UniProt: #Chromosome #Nucleus
Alternative name from UniProt:
Recommended name: DNA mismatch repair protein Msh6
Gene name from HGNC: MSH6 (GTBP)
HPA class: Cancer-related genes Disease related genes Human disease related genes Plasma proteins
AlphaFold DB: P52701
AlphaFold Link: https://alphafold.ebi.ac.uk/entry/P52701
HPA link: https://www.proteinatlas.org/ENSG00000116062-MSH6
Tissue specificity RNA from HPA: Low tissue specificity
Tissue expression from HPA: Ubiquitous nuclear expression.
Single cell type specificity Cell type enhanced (Granulosa cells, Theca cells)
Immune cell specificity: Low immune cell specificity
Subcellular summary HPA Located in Nucleoplasm, Golgi apparatus, Vesicles (CCD Transcript)
Cancer prognostic summary HPA Prognostic marker in renal cancer (unfavorable), endometrial cancer (unfavorable) and liver cancer (unfavorable)
Pathology link: https://www.proteinatlas.org/ENSG00000116062-MSH6/pathology
Pathology endo: https://www.proteinatlas.org/ENSG00000116062-MSH6/pathology/endometrial+cancer
Survival figure legend: Kaplan-Meier survival curves of all cases according to mismatch repair (MMR) status. (
Survival curve link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302284/figure/F1/
Phenotype ID: 614350 $ 608089 $ 619097 $ 114500$
Disease: Hereditary non-polyposis colorectal cancer 5 (HNPCC5) $Endometrial cancer (ENDMC) $ Mismatch repair cancer syndrome 3 (MMRCS3)
Note1: The disease is caused by variants affecting the gene represented in this entry $Disease susceptibility is associated with variants affecting the gene represented in this entry $The disease is caused by variants affecting the gene represented in this entry $
OMIM: 600678
OMIM link1: https://www.omim.org/entry/614350 $https://www.omim.org/entry/608089 $ https://www.omim.org/entry/619097 $
OMIM link2: https://www.omim.org/entry/600678
HGNC ID: HGNC:7329
HGNC link: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:7329